Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Neon Therapeutics Inc (NTGN)

Neon Therapeutics Inc (NTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 88,929
  • Shares Outstanding, K 28,967
  • Annual Sales, $ 0 K
  • Annual Income, $ -79,780 K
  • 60-Month Beta -0.81
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.15
Trade NTGN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.10
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 05/11/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.27
  • Number of Estimates 1
  • High Estimate -0.27
  • Low Estimate -0.27
  • Prior Year -0.79
  • Growth Rate Est. (year over year) +65.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.11 +45.50%
on 04/16/20
3.35 -8.36%
on 04/23/20
+0.54 (+21.34%)
since 04/03/20
3-Month
1.37 +124.09%
on 03/12/20
3.35 -8.36%
on 04/23/20
+1.60 (+108.84%)
since 02/05/20
52-Week
0.88 +248.86%
on 12/05/19
6.25 -50.88%
on 05/06/19
-3.06 (-49.92%)
since 05/03/19

Most Recent Stories

More News
ONK Therapeutics Appoints Hugh O’Dowd as Independent Chairman

ONK Therapeutics Ltd, an innovative natural killer (NK) cell therapy company, today announced that it has appointed Hugh O’Dowd as Director and independent Non-executive Chairman of its Board of Directors....

PBYI : 5.08 (+1.80%)
NTGN : 3.07 (+8.10%)
Infinity Pharmaceuticals Provides Company Update and First Quarter 2020 Financial Results

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced its first quarter 2020 financial results and provided an update on the Company, including its first quarter progress with IPI-549, the Company’s...

INFI : 0.0080 (-50.00%)
NTGN : 3.07 (+8.10%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, SBBX, QUMU, and MSBF Shareholders About Its Ongoing Investigations

NEW YORK, May 01, 2020 (GLOBE NEWSWIRE) --

NTGN : 3.07 (+8.10%)
SBBX : 18.51 (-4.29%)
QUMU : 0.8988 (+0.71%)
MSBF : 10.38 (+1.86%)
Neon Therapeutics Announces Acceptance of European Clinical Trial Authorization Application for NEO-PTC-01

Phase 1 Clinical Trial of Personal Neoantigen-Targeted T Cell Therapy Expected to Initiate in Third Quarter 2020

NTGN : 3.07 (+8.10%)
Rigrodsky & Long, P.A. Files Class Action Suit Against Neon Therapeutics, Inc.

WILMINGTON, Del., April 27, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of Delaware on...

NTGN : 3.07 (+8.10%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, SBBX, QUMU, and MSBF Shareholders About Its Ongoing Investigations

NEW YORK, April 24, 2020 (GLOBE NEWSWIRE) --

NTGN : 3.07 (+8.10%)
SBBX : 18.51 (-4.29%)
QUMU : 0.8988 (+0.71%)
MSBF : 10.38 (+1.86%)
NTGN, ETFC, TTPH, and MINI SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers

WILMINGTON, Del., April 21, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:

NTGN : 3.07 (+8.10%)
ETFC : 49.26 (-1.58%)
TTPH : 2.20 (-3.51%)
MINI : 29.50 (-6.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

Neon Therapeutics Inc. is a clinical-stage immuno-oncology company. It engaged in developing neoantigen-based therapeutics for the treatment of cancer by directing the immune system. The company's product pipeline consists of NEO-PV-01, NEO-PTC-01 and NEO-SV-01 which are in clinical stage. Neon Therapeutics...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 3.20
1st Resistance Point 3.13
Last Price 3.07
1st Support Level 2.96
2nd Support Level 2.85
3rd Support Level N/A

See More

52-Week High 6.25
Fibonacci 61.8% 4.20
Fibonacci 50% 3.57
Last Price 3.07
Fibonacci 38.2% 2.93
52-Week Low 0.88

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar